StockData

Sensata Technologies vs Trane Technologies

ST and TT side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ST and TT compare

Trane Technologies is the larger company, worth 15 times as much as Sensata Technologies ($90.2B against $5.9B).

On earnings, Trane Technologies is cheaper: it trades at 29.0× trailing earnings, against 67.1× for Sensata Technologies.

Trane Technologies grew revenue faster over the last twelve months (10.3% versus 0.80% for Sensata Technologies).

Trane Technologies keeps more of each dollar of sales as profit, with a net margin of 13.6% compared with 2.4% at Sensata Technologies.

Both pay dividends: Sensata Technologies yields 1.2% and Trane Technologies 0.77%.

Trane Technologies scores higher on the StockData Score (23 against 11 for Sensata Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSTTT
Size and price
Market cap$5.9B$90.2B
Share price$40.27$410.00
Change, 1 year23.4%−4.1%
Change, 5 years−32.6%122%
Beta (5Y)1.211.12
Employees21K45K
StockData Score
Total score1123 (better)
Valuation score24 (better)
Growth score14 (better)
Performance score26 (better)
Health score35 (better)
Dividend score34 (better)
Valuation
P/E67.1×29.0× (better)
P/S1.6× (better)3.9×
P/B2.0× (better)9.9×
EV/EBITDA15.1× (better)20.7×
P/FCF10.1× (better)23.6×
PEG–1.44
FCF yield9.9% (better)4.2%
Fair value$37.27$491.31
Margin of safety−8.1%16.5% (better)
Growth
Revenue growth (TTM)0.80%10.3% (better)
Revenue growth, 5Y average4.0%11.4% (better)
Net income growth (TTM)−19.3%7.5% (better)
EPS growth (TTM)−20.0%8.9% (better)
EPS growth, 5Y average−27.4%29.8% (better)
Profitability
Gross margin29.5%–
Operating margin7.5%17.9% (better)
Net margin2.4%13.6% (better)
FCF margin15.3%16.4% (better)
Return on equity3.1%36.1% (better)
Return on invested capital2.8%25.0% (better)
Financial health
Debt / equity0.820.46 (better)
Net debt / EBITDA3.860.92 (better)
Interest coverage2.0×19.2× (better)
Current ratio2.29 (better)1.12
Altman Z-score2.405.91 (better)
Piotroski F-score68 (better)
Dividends and buybacks
Dividend yield1.2% (better)0.77%
Payout ratio77.8%28.6%
Years of dividend growth–5
Dividend growth, 5Y average–12.1%
Buyback yield0.43%1.7% (better)
Shareholder yield1.6%2.5% (better)
Ownership
Held by institutions106%87.5%
Held by insiders1.0%0.22%
Insider net buying, 12 months−$8.0M (better)−$52.4M
Short interest, % of float5.1%1.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.